References
-
1) Downregulation of long non-coding RNA LINP1 inhibits the malignant progression of esophageal squamous cell carcinoma.
Product: SNAIL Antibody (#AF6032)Year: 2020Journal: ANN TRANSL MEDDOI: 10.21037/atm-20-1009PMID: 32617295 -
2) Cartilage Oligomeric Matrix Protein promotes epithelial-mesenchymal transition by interacting with Transgelin in Colorectal Cancer.
Product: SNAIL Antibody (#AF6032)Year: 2020Journal: THERANOSTICSImpactFactor: 12.4DOI: 10.7150/thno.44456PMID: 32754278 -
3) TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3β/β-Catenin/Snail1 Pathway in Bladder Cancer Cells.
Product: SNAIL Antibody (#AF6032)Year: 2020Journal: ONCOTARGETS THERImpactFactor: 2.7DOI: 10.2147/OTT.S251830PMID: 33061441 -
4) High CCL7 expression is associated with migration, invasion and bone metastasis of non-small cell lung cancer cells.
Product: SNAIL Antibody (#AF6032)Year: 2019Journal: AM J TRANSL RESImpactFactor: 1.7PMID: 30788000 -
5) MicroRNA-145 promotes the epithelial-mesenchymal transition in peritoneal dialysis-associated fibrosis by suppressing fibroblast growth factor 10.
Product: SNAIL Antibody (#AF6032)Year: 2019Journal: J BIOL CHEMImpactFactor: 4DOI: 10.1074/jbc.RA119.007404PMID: 31431501 -
6) Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway.
Product: SNAIL Antibody (#AF6032)Year: 2018Journal: RESP RESImpactFactor: 4.7DOI: 10.1186/s12931-018-0806-zPMID: 29871641 -
7) The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC).
Product: SNAIL Antibody (#AF6032)Year: 2018Journal: EUR J PHARMACOLImpactFactor: 4.2DOI: 10.1016/j.ejphar.2018.07.006PMID: 30017802 -
8) SOSTDC1 inhibits bone metastasis in non-small cell lung cancer and may serve as a clinical therapeutic target.
Product: SNAIL Antibody (#AF6032)Year: 2018Journal: INT J MOL MEDImpactFactor: 5.7DOI: 10.3892/ijmm.2018.3926PMID: 30320379 -
9) MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells.
Product: SNAIL Antibody (#AF6032)Year: 2015Journal: INT J ONCOLImpactFactor: 4.5DOI: 10.3892/ijo.2015.3144PMID: 26323677 -
10) EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells.
Product: SNAIL Antibody (#AF6032)Year: 2015Journal: SCI REP-UKImpactFactor: 3.8DOI: 10.1038/srep11009PMID: 26046674 -
11) Fast freezing inhibits melanin synthesis of melanocytes by modulating the Wnt/β-catenin signalling pathway.
Product: MITF Antibody (#AF6027)Year: 2024Journal: Exp DermatolImpactFactor: 3.5DOI: 10.1111/exd.15101PMID: 38770555 -
12) The critical role of ROS in Ermanin-induced melanogenesis.
Product: MITF Antibody (#AF6027)Year: 2021Journal: Free Radic Biol MedImpactFactor: 7.1DOI: 10.1016/j.freeradbiomed.2021.09.017PMID: 34560247 -
13) Evaluating Salidroside as a Therapeutic Agent for Vascular Calcification Using Network Pharmacology and Experimental Rat Models.
Product: JAK2 Antibody (#AF6022)Year: 2025Journal: J Vis ExpImpactFactor: 1.2DOI: 10.3791/67728PMID: 39960197 -
14) MiR362-3p Alleviates Osteosarcoma by Regulating the IL6ST/JAK2/STAT3 Pathway in Vivo and in Vitro.
Product: JAK2 Antibody (#AF6022)Year: 2024Journal: Technol Cancer Res TreatImpactFactor: 2.7DOI: 10.1177/15330338241261616PMID: 39051528 -
15) Zhiqiao Gancao decoction regulated JAK2/STAT3/ macrophage M1 polarization to ameliorate intervertebral disc degeneration.
Product: JAK2 Antibody (#AF6022)Year: 2024Journal: HeliyonImpactFactor: 4DOI: 10.1016/j.heliyon.2024.e34715PMID: 39170327